Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Recent studies have indicated the existence of tumorigenesis barriers that slow or inhibit the progression of preneoplastic lesions to neoplasia. One such barrier involves DNA replication stress, which leads to activation of the DNA damage checkpoint and thereby to apoptosis or cell cycle arrest, whereas a second barrier is mediated by oncogene-induced senescence. The relationship between these two barriers, if any, has not been elucidated. Here we show that oncogene-induced senescence is associated with signs of DNA replication stress, including prematurely terminated DNA replication forks and DNA double-strand breaks. Inhibiting the DNA double-strand break response kinase ataxia telangiectasia mutated (ATM) suppressed the induction of senescence and in a mouse model led to increased tumour size and invasiveness. Analysis of human precancerous lesions further indicated that DNA damage and senescence markers cosegregate closely. Thus, senescence in human preneoplastic lesions is a manifestation of oncogene-induced DNA replication stress and, together with apoptosis, provides a barrier to malignant progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oncogene activation is a powerful inducer of cellular senescence. Oncogene expression triggers an initial hyperproliferative phase that is intrinsically associated with altered DNA replication, which eventually engages DDR pathways and causes senescence7,8,39”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [8]
In the citing paper
“It has been shown that one mechanism for the link between the initial mitotic reaction and senescence induction is the S-phase-associated DDR: The oncogenic stress drives increased DNA replication origins, leading to accumulation of incomplete replication intermediates, resulting in DNA damage and activation of the DDR kinases (ATM, ATR, CHK2, and CHK1) (Bartkova et al. 2006; Di Micco et al. 2006;”
From Cellular senescence and its effector programs (2014) · cites this paper as Bartkova et al. 2006
In the citing paper
“Colon adenomas, which are stable precursor lesions of invasive colon cancer, were found to be negative for the proliferation marker Ki67 and positive for SA- β- gal 87,88 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [87]
In the citing paper
“colon adenoma- derived samples also have elevated expression of p16 INK4a , HP1γ (an H3K9me3- enriched senescence- associated heterochromatin focus- promoting scaffold that connects H3K9 methyltransferases to Rb as another binding partner), and focal γH2AX expression, indicating enhanced DNA damage 87,89 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [87]
In the citing paper
“In particular, E1A inhibits p53 phosphorylation at serine 15 (14), a hallmark of the activation of the DNA damage response during senescence (3, 12).”
From Mitochondrial Dysfunction Contributes to Oncogene-Induced Senescence (2009) · cites this paper as [3]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,291
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Self-citationRb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Self-citationCrucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482
Cited by
Items 601–700 of 1,016
FBP1 controls liver cancer evolution from senescent MASH hepatocytes
Gu, L., Zhu, Y., Nandi, S. P., Lee, M., Watari, K., Bareng, B., Ohira, M., Liu, Y., Sakane, S., Carlessi, R., et al. (2025) · Nature · doi:10.1038/s41586-024-08317-9 · Cited by 74
Prevention of premature senescence requires JNK regulation of Bcl-2 and reactive oxygen species
Lee, J. J., Lee, J. H., Ko, Y. G., Hong, S., & Js, L. (2009) · Oncogene · doi:10.1038/onc.2009.355 · Cited by 73
“As the DNA damage signaling pathway ATM/CHK2/p53 is a critical mediator of oncogene-induced senescence and apoptosis (Bartkova et al., 2006; Mallette et al., 2007), we hypothesize that migration of Bax to the mitochondria because of the JNK activity is a critical determinant in deciding cell fate…”
BackgroundCuadrado, M., Gutierrez‐Martinez, P., Swat, A., Nebreda, Á. R., & Fernández-Capetillo, Ó. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0729 · Cited by 89
Macleod, K. F. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2504 · Cited by 74
Sohn, J. J., Schetter, A. J., Yfantis, H. G., Ridnour, L. A., Horikawa, I., Khan, M. A., Robles, A. I., Hussain, S. P., Goto, A., Bowman, E. D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044156 · Cited by 66
“We determined levels of DDR markers associated with premature senescence [11,12] by IHC in the epithelial cells of IBD and normal colons.”
BackgroundInfluentialRsf-1, a Chromatin Remodeling Protein, Induces DNA Damage and Promotes Genomic Instability
Sheu, J. J., Guan, B., Choi, J., Lin, A. W., Lee, C., Hsiao, Y.-T., Wang, T., Tsai, F., & Shih, I. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.138735 · Cited by 70
Cellular senescence and protein degradation: Breaking down cancer
Deschênes-Simard, X., Lessard, F., Gaumont-Leclerc, M.-F., Bardeesy, N., & Ferbeyre, G. (2014) · Cell Cycle · doi:10.4161/cc.29335 · Cited by 61
“In addition to increased ROS levels, oncogenic activation drives an initial phase of DNA hyper-replication, leading to premature termination of replication forks, thereby producing DNA damage that triggers senescence.(106,107) Intriguingly, another candidate target of SAPD identified by proteomics is TOP2 (Table 1), w…”
BackgroundTranslational research in radiation-induced DNA damage signaling and repair
Nickoloff, J. A., Boss, M., Allen, C., & LaRue, S. Μ. (2017) · Translational Cancer Research · doi:10.21037/tcr.2017.06.02 · Cited by 72
“Overexpression of RAD51 is likely both an adaptation to oncogenic replication stress (27,102) and a driver of tumor progression via genome destabilization (103,104).”
BackgroundPARP Inhibitors in Prostate Cancer–the Preclinical Rationale and Current Clinical Development
Virtanen, V., Paunu, K., Ahlskog, J. K., Várnai, R., Sipeky, C., & Sundvall, M. (2019) · Genes · doi:10.3390/genes10080565 · Cited by 72
“Genomic instability is an inherent property of most malignancies [2].”
BackgroundMutational signatures reveal the role of RAD52 in p53-independent p21-driven genomic instability
Galanos, P., Pappas, G., Polyzos, A., Kotsinas, A., Svolaki, I., Giakoumakis, N. N., Glytsou, C., Pateras, I. S., Swain, U., Souliotis, V. L., et al. (2018) · Genome Biology · doi:10.1186/s13059-018-1401-9 · Cited by 67
Self-citationElsallabi, O., Patruno, A., Pesce, M., Cataldi, A., Carradori, S., & Gallorini, M. (2022) · Molecules · doi:10.3390/molecules27030738 · Cited by 67
Immunosenescence in atherosclerosis: A role for chronic viral infections
Talepoor, A. G., & Doroudchi, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.945016 · Cited by 71
Chen, L., Zhang, W., Chen, D., Yang, Q., Sun, S., Dai, Z., Li, Z., Liang, X., Chen, C., Jiao, Y., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01367-x · Cited by 71
“33,34,71 Herein, our fi nding uncovered that RBM4 could be upregulated in pre-cancerous cells or cancer cells to evade senescence and maintain malignancy via suppressing LKB1 activity.”
Zeppernick, F. A., Ardighieri, L., Hannibal, C. G., VANG, R. S., Junge, J., Kjær, S. K., Zhang, R., Kurman, R. J., & Shih, I. (2014) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000313 · Cited by 69
Rescue from replication stress during mitosis
Fragkos, M., & Naim, V. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1288322 · Cited by 70
DNA repair factor RAD18 and DNA polymerase Polκ confer tolerance of oncogenic DNA replication stress
Yang, Y., Gao, Y., Mutter-Rottmayer, L., Zlatanou, A., Durando, M., Ding, W., Wyatt, D. W., Ramsden, D. A., Tanoue, Y., Tateishi, S., et al. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201702006 · Cited by 74
“Many oncogenes, including v-RAS, cyclin E, and others, induce DNA replication defects that trigger DNA damage signaling (including ATM–CHK2, ATR–CHK1, and p53) and lead to irreversible cell cycle exit often termed oncogene-induced senescence (OIS; Bartkova et al., 2006; Di Micco et al., 2006).”
InfluentialKnudsen, E. S., Kumarasamy, V. M., Ruiz, A., Sivinski, J., Chung, S., Grant, A. D., Vail, P. J., Chauhan, S. S., Jie, T., Riall, T. S., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0650-0 · Cited by 68
“In these tumors it has been hypothesized that CDKN2A loss represents an important event that allows bypass of KRAS-induced senescence 3, 40 .”
Zhang, S., Luo, Y., Zeng, H., Wang, Q., Tian, F., Song, J., & Cheng, W. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.09.014 · Cited by 72
RAS Transformation Requires CUX1-Dependent Repair of Oxidative DNA Damage
Ramdzan, Z. M., Vadnais, C., Pal, R., Vandal, G., Cadieux, C., Leduy, L., Davoudi, S., Hulea, L., Yao, L., Karnezis, A. N., et al. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001807 · Cited by 62
Rai, P. (2010) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2010.07.010 · Cited by 73
“Activation of oncogenes in normal cells induces premature senescence [28,29,117].”
BackgroundSidi, R., Pasello, G., Opitz, I., Soltermann, A., Tutic, M., Rehrauer, H., Weder, W., Stahel, R. A., & Felley‐Bosco, E. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.09.044 · Cited by 71
FANCD2 Activates Transcription of TAp63 and Suppresses Tumorigenesis
Park, E., Kim, H., Kim, J. M., Primack, B., Vidal-Cardenas, S. L., Xu, Y., Price, B. D., Mills, A. A., & D’Andrea, A. D. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.05.017 · Cited by 70
“In this regard, the Fancd2-Ub tumor-suppressor activity is similar to the prosenescence tumor-suppressor activity observed for other DDR proteins, such as ATM (Bartkova et al., 2006) and CHK2 (Di Micco et al., 2006).”
Suppression of p16 Induces mTORC1-Mediated Nucleotide Metabolic Reprogramming
Buj, R., Chen, C.-W., Dahl, E. S., Leon, K. E., Kuskovsky, R., Maglakelidze, N., Navaratnarajah, M., Zhang, G., Doan, M. T., Jiang, H., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.084 · Cited by 64
p16INK4a‐induced senescence is disabled by melanoma‐associated mutations
Haferkamp, S., Becker, T. M., Scurr, L. L., Kefford, R. F., & Rizos, H. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00422.x · Cited by 59
“Furthermore, the DNA damage checkpoint, which mediates oncogene- induced senescence (Bartkova et al., 2006; Di Micco et al., 2006), was not induced by p16INK4a induction as there was no evidence of increased DNA damage foci in p16INK4a-expressing cells, as marked by H2AX phosphorylation (data not…”
BackgroundActivated p53 induces NF-κB DNA binding but suppresses its transcriptional activation
Kawauchi, K., Araki, K., Tobiume, K., & Tanaka, N. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.05.021 · Cited by 75
Kaufmann, W. K., Nevis, K. R., Qu, P., Ibrahim, J. G., Zhou, T., Zhou, Y., Simpson, D. A., Helms-Deaton, J., Cordeiro-Stone, M., Moore, D. T., et al. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700935 · Cited by 65
“This condition of enhanced DNA damage and activation of the DNA damage response was induced in normal human fibroblasts by expression of gene products such as CDC6, cyclin E, and E2F1 that drive cells into a precocious S phase and by activated oncogenes, including H-RAS (Bartkova et al., 2005, 2006; Di Micco et al., 2…”
BackgroundMagkouta, S., Veroutis, D., Papaspyropoulos, A., Georgiou, M., Lougiakis, N., Pippa, Ν., Havaki, S., Palaiologou, A., Thanos, D.-F., Kambas, K., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00747-4 · Cited by 67
Self-citationMoon, N.-S., Stefano, L. D., Morris, E. J., Patel, R. G., White, K., & Dyson, N. J. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000153 · Cited by 69
“Given the recent studies showing that an activated DNA damage response is a hallmark of pre-neoplastic lesions [40], it is particularly interesting that DNA damage-induced apoptosis is one setting where the strong synergy between E2F and p53 is conserved between flies and humans.”
BackgroundAlmeida, L. O., Guimarães, D. M., Martins, M. D., Martins, M. A. T., Warner, K. A., Nor, J. E., CASTILHO, R. M., & SQUARIZE, C. H. (2017) · Stem Cell Research · doi:10.1016/j.scr.2017.04.003 · Cited by 71
Therapy-induced polyploidization and senescence: Coincidence or interconnection?
Sikora, E., Czarnecka‐Herok, J., Bojko, A., & Sunderland, P. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.11.015 · Cited by 68
Senescence in polyploid giant cancer cells: A road that leads to chemoresistance
Bharadwaj, D., & Mandal, M. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2019.11.002 · Cited by 64
The concerted roles of FANCM and Rad52 in the protection of common fragile sites
Wang, H., Li, S., Oaks, J. J., Ren, J., Li, L., & Wu, X. (2018) · Nature Communications · doi:10.1038/s41467-018-05066-y · Cited by 64
p53 in senescence – it's a marathon, not a sprint
Sheekey, E., & Narita, M. (2021) · FEBS Journal · doi:10.1111/febs.16325 · Cited by 67
Functional genomic screens identify CINP as a genome maintenance protein
Lovejoy, C. A., Xu, X., Bansbach, C. E., Glick, G. G., Zhao, R., Ye, F., Sirbu, B. M., Titus, L. C., Shyr, Y., & Cortez, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909345106 · Cited by 67
Freije, A., Molinuevo, R., Ceballos, L., Cagigas, M., Alonso‐Lecue, P., Rodríguez, R., Menéndez, P. R., Aberdam, D., de Diego, E., & Gandarillas, A. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.012 · Cited by 68
Shimura, T., Ochiai, Y., Noma, N., Oikawa, T., Sano, Y., & Fukumoto, M. (2013) · Cell Cycle · doi:10.4161/cc.23719 · Cited by 67
“5% SDS in instability and acceleration of tumor progression.(21,22) The structure-specific Mus81/Eme1 complex is produced in response to this type of replication perturbation to control genomic stability during DNA replication.”
BackgroundChromatin unfolding by Cdt1 regulates MCM loading via opposing functions of HBO1 and HDAC11-geminin
Wong, P. G., Glozak, M. A., Cao, T. V., Vaziri, C., Seto, E., & Alexandrow, M. G. (2010) · Cell Cycle · doi:10.4161/cc.9.21.13596 · Cited by 77
“2006) while the expression of other oncogenes, including mos, cdc6, and cycline E led to senescence dependent on functioning DNA damage repair machinery, which is normally activated as a consequence of double strand breaks reflective of re-replication and genomic instability (Bartkova et al. 2006).”
BackgroundLimited Role of Murine ATM in Oncogene-Induced Senescence and p53-Dependent Tumor Suppression
Efeyan, A., Murga, M., Martinez-Pastor, B., Ortega-Molina, A., Soria, R., Collado, M., Fernandez-Capetillo, O., & Serrano, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005475 · Cited by 58
“. Second, inactivation of individual components of the DNA damage response, such as ATM, in cultured human fibroblasts eliminates oncogene-induced senescence and renders these cells permissive to oncogene-driven proliferation”
BackgroundTranscription-Associated Genome Instability
Gaillard, H., Herrera-Moyano, E., & Aguilera, A. (2013) · Chemical Reviews · doi:10.1021/cr400017y · Cited by 60
Hypoxia driven glycation: Mechanisms and therapeutic opportunities
Khan, M. I., Rath, S., Adhami, V. M., & Mukhtar, H. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.05.008 · Cited by 75
Regulation of Senescence in Cancer and Aging
Kong, Y., Cui, H., Ramkumar, C., & Zhang, H. (2011) · Journal of Aging Research · doi:10.4061/2011/963172 · Cited by 69
Linking replication stress with heterochromatin formation
Nikolov, I., & Taddei, A. (2015) · Chromosoma · doi:10.1007/s00412-015-0545-6 · Cited by 68
“CAF1 is conserved in budding yeast, where it also contributes to the maintenance of silent chromatin (Enomoto and Berman 1998) and genome stability (Kaufman et al. 1997).”
IGFBP7 Is Not Required for B-RAF-Induced Melanocyte Senescence
Scurr, L. L., Pupo, G. M., Becker, T. M., Lai, K., Schrama, D., Haferkamp, S., Irvine, M., Scolyer, R. A., Mann, G. J., Becker, J. C., et al. (2010) · Cell · doi:10.1016/j.cell.2010.04.021 · Cited by 65
“Ectopically expressed B-RAFV600E was detected using an antibody against the MYC epitope and endogenous B-RAF in the NM39 cells was detected with the antibody against B-RAF.”
BackgroundPlk1 Inhibition Causes Post-Mitotic DNA Damage and Senescence in a Range of Human Tumor Cell Lines
Driscoll, D. L., Chakravarty, A., Bowman, D., Shinde, V., Lasky, K., Shi, J. Q., Vos, T. J., Stringer, B., Amidon, B., D’Amore, N. R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111060 · Cited by 67
Ras Activation Induces Expression of Raet1 Family NK Receptor Ligands
Liu, X. V., Ho, S. S. W., Tan, J. J., Kamran, N., & Gasser, S. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200965 · Cited by 60
“Discussion Activation of oncogenes induces replication and oxidative stress leading to the accumulation of DNA damage in cells (9, 10, 12).”
BackgroundSOCS1, a novel interaction partner of p53 controlling oncogene-induced senescence
Mallette, F. A., Calabrese, V., Ilangumaran, S., & Ferbeyre, G. (2010) · Aging · doi:10.18632/aging.100163 · Cited by 70
“ATM is an important mediator of the senescence response by activating the p53 pathway, mainly through phosphorylation of the Ser 15 residue [28,45,46].”
Inhibition of DNA2 nuclease as a therapeutic strategy targeting replication stress in cancer cells
Kumar, S., Peng, X., Daley, J. M., Yang, L., Shen, J., Nguyen, N. C., Bae, G., Niu, H., Peng, Y., Hsieh, H.-J., et al. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.15 · Cited by 63
Raad, H., Serrano-Sanchez, M., Harfouche, G., Mahfouf, W., Bortolotto, D., Bergeron, V., Kasraian, Z., Dousset, L., Hosseini, M., Taieb, A., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.12.027 · Cited by 62
“DDR inactivation allows the oncogeneinduced senescence to be bypassed and thus induces the proliferation of oncogene-expressing cells and their transformation (Bartkova et al., 2006; Di Micco et al., 2006).”
Backgroundp16INK4a Regulates Cellular Senescence in PD-1-Expressing Human T Cells
Janelle, V., Neault, M., Lebel, M., Sousa, D. M. D., Boulet, S., Durrieu, L., Carli, C., Muzac, C., Lemieux, S., Labrecque, N., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.698565 · Cited by 67
Li, S., Kong, L., Meng, Y., Chen, C., Lemacon, D. S., Yang, Z., Tan, K., Cheruiyot, A., Lu, Z., & You, Z. (2023) · Molecular Cell · doi:10.1016/j.molcel.2022.12.034 · Cited by 64
Distinct Phosphatases Mediate the Deactivation of the DNA Damage Checkpoint Kinase Rad53
Travesa, A., Duch, A., & Quintana, D. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801402200 · Cited by 70
Replication Checkpoint: Tuning and Coordination of Replication Forks in S Phase
Hustedt, N., Gasser, S. M., & Shimada, K. (2013) · Genes · doi:10.3390/genes4030388 · Cited by 75
The multiple facets of the intra-S checkpoint
Grallert, B., & Boye, E. (2008) · Cell Cycle · doi:10.4161/cc.6389 · Cited by 73
Ohtani, N., Yamakoshi, K., Takahashi, A., & Hara, E. (2010) · Cell Division · doi:10.1186/1747-1028-5-1 · Cited by 62
“Our results strongly suggest that the DNA damage response (DDR) triggered by hyper-cell proliferation [50-52] plays critical role(s) in blocking DNMT1 gene expression, at least partly, through the elevation of the reactive oxygen species (ROS) level in late-stage papillomas [37].”
Nichols, B. A., Oswald, N. W., McMillan, E. A., McGlynn, K., Yan, J., Kim, M. S., Saha, J., Mallipeddi, P. L., LaDuke, S. A., Villalobos, P. A., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1377 · Cited by 66
“pathways and subsequent apoptosis or senescence (45).”
DNA Damage Response and Inflammatory Signaling Limit the MLL-ENL-Induced Leukemogenesis In Vivo
Takáčová, S., Slany, R. K., Bártková, J., Stránecký, V., Doležel, P., Lužná, P., Bártek, J., & Divoký, V. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.021 · Cited by 66
Absence of Distinguishing Senescence Traits in Human Melanocytic Nevi
Tran, S. L., Haferkamp, S., Scurr, L. L., Gowrishankar, K., Becker, T. M., Desilva, C., Thompson, J. F., Scolyer, R. A., Kefford, R. F., & Rizos, H. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.126 · Cited by 69
Clinically non-functioning pituitary adenomas: Pathogenic, diagnostic and therapeutic aspects
Mercado, M., Melgar, V., Salame, L., & Cuenca, D. (2017) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2017.05.009 · Cited by 72
Radiotherapy-Induced Senescence and its Effects on Responses to Treatment
Tabasso, A. F. S., Jones, D. J. L., Jones, G. D. D., & Macip, S. (2019) · Clinical Oncology · doi:10.1016/j.clon.2019.02.003 · Cited by 63
Vitamin D/vitamin D receptor axis regulates DNA repair during oncogene-induced senescence
Graziano, S., Johnston, R., Deng, O., Zhang, J., & Gonzalo, S. (2016) · Oncogene · doi:10.1038/onc.2016.77 · Cited by 60
Escape from senescence: molecular basis and therapeutic ramifications
Evangelou, K., Belogiannis, K., Papaspyropoulos, A., Petty, R., & Gorgoulis, V. G. (2023) · The Journal of Pathology · doi:10.1002/path.6164 · Cited by 63
“This work, along with earlier pioneering studies, led in 2008 to the proposal of the oncogene-induced DNA damage model for cancer development [12,13,80].”
BackgroundResultSelf-citationSasaki, M., Miyakoshi, M., Sato, Y., & Nakanuma, Y. (2012) · Liver International · doi:10.1111/j.1478-3231.2011.02656.x · Cited by 59
“Cellular senescence is a delayed stress response involving multiple effector mechanisms such as the DNA damage response (13) and the senescence-associated secretion phenotype (14–16).”
BackgroundCorpet, A., & Stucki, M. (2014) · Chromosoma · doi:10.1007/s00412-014-0469-6 · Cited by 63
“In addition, overexpression of activated oncogenes such as H-RasV12 induces a DNA damage response that ultimately leads to oncogene-induced senescence (OIS) that can act as an anticancer barrier (Serrano et al. 1997; Bartkova et al. 2006; Di Micco et al. 2006; Mallette et al. 2007).”
BackgroundRass, U. (2013) · Chromosoma · doi:10.1007/s00412-013-0431-z · Cited by 61
“More pleiotropically acting endogenous replication stress, associated with oncogene activation, has been identified as a candidate driver in the development of cancer (Bartkova et al. 2005, 2006; Di Micco et al. 2006; Gorgoulis et al. 2005).”
BackgroundReddy, J. P., Peddibhotla, S., Bu, W., Zhao, J., Haricharan, S., Du, Y. N., Podsypanina, K., Rosen, J. M., Donehower, L. A., & Li, Y. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910665107 · Cited by 64
“Residual expression of senescent markers has also been noted in advanced human colon and urinary carcinomas (12).”
BackgroundHTLV-1 Tax: Linking transformation, DNA damage and apoptotic T-cell death
Chlichlia, K., & Khazaie, K. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.06.005 · Cited by 64
Regulation of Cdc45 in the cell cycle and after DNA damage
Broderick, R., & Nasheuer, H. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370926 · Cited by 60
Hubackova, S., Novakova, Z., Krejcikova, K., Kosar, M., Dobrovolna, J., Duskova, P., Hanzlikova, H., Vancurova, M., Barath, P., Bartek, J., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.15.12521 · Cited by 56
“Inhibition of DDR emanating from these lesions results in bypass of senescence.(11,72,73) It is presently thought therefore that such permanent DDR signaling is a prerequisite for promotion and long-term maintenance of the senescent state.”
BackgroundKawasumi, M., Lemos, B., Bradner, J. E., Thibodeau, R., Kim, Y.-S., Schmidt, M., Higgins, E., Koo, S.-W., Angle-Zahn, A., Chen, A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111378108 · Cited by 57
“Furthermore, caffeine administration or ATR suppression promotes oncogenic Ras-induced tumorigenesis (33, 36).”
Bolesta, E., Pfannenstiel, L. W., Demelash, A., Lesniewski, M. L., Tobin, M., Schlanger, S. E., Nallar, S. C., Papadimitriou, J. C., Kalvakolanu, D. V., & Gastman, B. R. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06214-11 · Cited by 58
“There is growing evidence that senescence is a major barrier in the development of cancer (1, 4).”
BackgroundAndrogen receptor levels are upregulated by Akt in prostate cancer
Ha, S., Ruoff, R., Kahoud, N., Franke, T. F., & Logan, S. K. (2011) · Endocrine Related Cancer · doi:10.1530/erc-10-0204 · Cited by 65
“Similar observations have been made in mouse models in which oncogene-induced stress is found to be associated with signs of replication-induced stress and leads to cellular senescence as indicated by increased levels of g-H2AX S139 and phospho-Chk2 (Bartkova et al. 2006).”
The Dual Roles of MYC in Genomic Instability and Cancer Chemoresistance
Kumari, A., Folk, W. P., & Sakamuro, D. (2017) · Genes · doi:10.3390/genes8060158 · Cited by 61
“Because oncogenic RAS [98,99] and oncogenic RAF , which functions downstream of the RAS protein family [100], can also induce premature senescence in normal fibroblasts, oncogene-induced checkpoint mechanisms are not MYC-specific functions, but broadly triggered by oncogenic stress and subsequent acceleration of cell-…”
BackgroundYu, X., Liu, Y., Yin, L., Peng, Y., Peng, Y., Gao, Y., Yuan, B., Zhu, Q., Cao, T., Xie, B., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0460-4 · Cited by 63
DNA Replication Stalling Attenuates Tyrosine Kinase Signaling to Suppress S Phase Progression
Shields, B. J., Hauser, C., Bukczynska, P. E., Court, N. W., & Tiganis, T. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.06.003 · Cited by 64
Evangelou, K., Bartkova, J., Kotsinas, A., Pateras, I. S., Liontos, M., Velimezi, G., Kosar, M., Liloglou, T., Trougakos, I. P., Dyrskjot, L., et al. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.76 · Cited by 59
“Finally, at day 10, control and treated cells were fixed in 1% paraformaldehyde, processed for Sa-b-gal activity and counterstained with nuclear fast red, as described elsewhere.(9) BJ cells conditionally expressing Ha-Ras were fixed at day 18 and stained with Senescence b-Galactosidase Staining Kit (Cell Signalling,…”
MethodSelf-citationMagkouta, S., Veroutis, D., Pousias, A., Papaspyropoulos, A., Pippa, N., Lougiakis, N., Kambas, K., Lagopati, N., Polyzou, A., Georgiou, M., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.09.006 · Cited by 59
Self-citationCarbonneau, C. L., Despars, G., Rojas-Sutterlin, S., Fortin, A., Le, O., Hoang, T., & Beauséjour, C. M. (2012) · Blood · doi:10.1182/blood-2011-06-361626 · Cited by 59
Multiple facets of p53 in senescence induction and maintenance
Johmura, Y., & Nakanishi, M. (2016) · Cancer Science · doi:10.1111/cas.13060 · Cited by 59
Defective Replication Stress Response Is Inherently Linked to the Cancer Stem Cell Phenotype
McGrail, D. J., Lin, C. C.-J., Dai, H., Mo, W., Li, Y., STEPHAN, C. C., Davies, P. J., Lu, Z., Mills, G. B., Lee, J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.068 · Cited by 60
Kasitinon, S. Y., Eskiocak, U., Martin, M., Bezwada, D., Khivansara, V., Tasdogan, A., Zhao, Z., Mathews, T. P., Aurora, A. B., & Morrison, S. J. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.086 · Cited by 62
“While cancer cells depend upon the activation of oncogenic signaling pathways, activation of these pathways can have deleterious consequences that impair proliferation and survival (Bartkova et al., 2006; Braig et al., 2005; Chen et al., 2005; Evan et al., 1992; Peterson et al., 2009).”
Cytokine loops driving senescence
Bártek, J., Hodný, Z., & Lukas, J. (2008) · Nature Cell Biology · doi:10.1038/ncb0808-887 · Cited by 61
Self-citationUsing Mice to Examine p53 Functions in Cancer, Aging, and Longevity
Donehower, L. A. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001081 · Cited by 55
“Histopathological examination of tissues with preneoplastic lesions often shows an increase in fractions of apoptotic or senescent cells accompanying an elevated proliferation rate (Bartkova et al. 2005; Gorgoulis et al. 2005; Bartkova et al. 2006; Halazonetis et al. 2008).”
BackgroundInfluentialOlivares‐Illana, V., & Fåhræus, R. (2010) · Oncogene · doi:10.1038/onc.2010.266 · Cited by 65
“p21 are, however, downstream effectors to a wide variety of stress pathways that merge on pRb through the suppression of cyclin/CDK activity (Bartkova et al., 2006; Feldser and Greider, 2007).”
BackgroundThe complex nature of fragile site plasticity and its importance in cancer
Sarni, D., & Kerem, B. (2016) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2016.03.017 · Cited by 59
Anacker, D. C., Aloor, H. L., Shepard, C., Lenzi, G. M., Johnson, B. A., Kim, B., & Moody, C. A. (2016) · Virology · doi:10.1016/j.virol.2016.09.028 · Cited by 60
“Increasing evidence supports the idea that oncogenes induce replication stress, especially those that promote uncontrolled S-phase entry (Bartkova et al., 2006; Di Micco et al., 2006; Halazonetis et al., 2008; Mallette et al., 2007).”
BackgroundTetraploidy in cancer and its possible link to aging
Tanaka, K., Goto, H., Nishimura, Y., Kasahara, K., Mizoguchi, A., & Inagaki, M. (2018) · Cancer Science · doi:10.1111/cas.13717 · Cited by 61
Helbling-Leclerc, A., Garcin, C., & Rosselli, F. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00764-5 · Cited by 61
Cellular senescence or stemness: hypoxia flips the coin
Otero-Albiol, D., & Carnero, A. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02035-0 · Cited by 58
SoRelle, E. D., Dai, J., Reinoso-Vizcaíno, N. M., Barry, A. P., Chan, C. C. W., & Luftig, M. A. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111286 · Cited by 60
Wang, Z., Liu, Y., Takahashi, M., Hook, K. V., Kampa-Schittenhelm, K. M., Sheppard, B. C., Sears, R. C., Stork, P. A., & Lopez, C. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201514110 · Cited by 59
Role of sirtuins in chronic obstructive pulmonary disease
Chun, P. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0494-2 · Cited by 57
The replicometer is broken: telomeres activate cellular senescence in response to genotoxic stresses
Suram, A., & Herbig, U. (2014) · Aging Cell · doi:10.1111/acel.12246 · Cited by 60
“…cells also display a greater number of asymmetric and prematurely terminated replication forks compared to controls, which is also observed in cyclin E expressing cells (Bartkova et al., 2006), demonstrating that oncogene expression blocks DNA replication fork progression (Di Micco et al., 2006).”
BackgroundRoberts, S. A., & Gordenin, D. A. (2014) · BioEssays · doi:10.1002/bies.201300140 · Cited by 56
Kurfürstová, D., Bártková, J., Vrtěl, R., Mičková, A., Burdová, A., Majera, D., Mistrík, M., Král, M., Santer, F. R., Bouchal, J., et al. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.02.005 · Cited by 58
Cyclin E Deregulation and Genomic Instability
Teixeira, L. K., & Reed, S. I. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-6955-0_22 · Cited by 61
Benedict, B., van Schie, J. J. M., Oostra, A. B., Balk, J. A., Wolthuis, R. M. F., Riele, H. T., & de Lange, J. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.01.024 · Cited by 59
Cdt1 and Geminin in cancer: markers or triggers of malignant transformation?
Petropoulou, C., Κοταντάκη, Π., Karamitros, D., & Taraviras, S. (2008) · Frontiers in bioscience · doi:10.2741/3018 · Cited by 59
“Recent studies provide evidence that activation of oncogenes in a precancerous lesion is accompanied by hyperproliferation and DNA hyper-replication (72, 73).”
BackgroundSIRT1 is required for the effects of rapamycin on high glucose-inducing mesangial cells senescence
Zhang, S., Cai, G., Fu, B., Feng, Z., Ding, R., Bai, X., Liu, W., Zhuo, L., Sun, L., Liu, F., et al. (2012) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2012.04.005 · Cited by 58
“Cellular senescence acts as a barrier to malignant cell transformation in vivo (Campisi, 2005) and may contribute to organismal aging (Bartkova et al., 2006; Collado et al., 2007; Halazonetis et al., 2008).”
BackgroundThe paradox of senescent-marker positive cancer cells: challenges and opportunities
O’Sullivan, E. A., Wallis, R., Mossa, F., & Bishop, C. L. (2024) · npj Aging · doi:10.1038/s41514-024-00168-y · Cited by 62
“In humans, melanocytic naevi 6 , and adenomas of both the lung 10 and colon 18 , demonstrate high expression of the senescence marker p16 in the pre-malignant but not the malignant counterpart, reinforcing the early protective role of senescence in cancer.”
BackgroundA Sensitive Method to Quantify Senescent Cancer Cells
Cahu, J., & Sola, B. (2013) · Journal of Visualized Experiments · doi:10.3791/50494 · Cited by 39
Metadata
- Authors
- Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., Takaoka, M., Nakagawa, H., Tort, F., Fugger, K., Johansson, F., Sehested, M., Andersen, C. L., Dyrskjot, L., Ørntoft, T., Lukas, J., Kittas, C., Helleday, T., Halazonetis, T. D., Bartek, J., & Gorgoulis, V. G.
- Affiliations
- The Wistar Institute (US)
- National and Kapodistrian University of Athens (GR)
- National Centre of Scientific Research "Demokritos" (GR)
- Stockholm University (SE)
- University of Ioannina (GR)
- National Hellenic Research Foundation (GR)
- University of Pennsylvania (US)
- Danish Cancer Society (DK)
- Copenhagen University Hospital (DK)
- Aarhus University Hospital (DK)
- Corresponding author
- Halazonetis, Thanos D.
- ORCID
- Venue
- Nature
- Published
- 2006-11
- Volume
- 444
- Issue
- 7119
- Pages
- 633-637
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2041156660
- Cited by
- 1,986
- References
- 30
- Citations by year
- 2026: 35 · 2025: 74 · 2024: 65 · 2023: 92 · 2022: 74 · 2021: 96 · 2020: 88 · 2019: 83 · 2018: 108 · 2017: 100 · 2016: 122 · 2015: 88 · 2014: 134 · 2013: 129 · 2012: 132
- FWCI
- 65.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- National Hellenic Research Foundation Helios Repository (National Hellenic Research Foundation) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- oncogene-induced senescence, DNA damage response, replication stress, DNA double-strand breaks, ATM kinase, precancerous lesions, senescence markers, tumor progression, apoptosis
- MeSH terms
- Animals, Cell Line, Cell Transformation, Neoplastic, DNA, DNA Damage, DNA Replication, Humans, Neoplasm Invasiveness, Nuclear Proteins, Oncogenes, Precancerous Conditions, Genes, mos, Cellular Senescence, Cell Cycle Proteins, Cyclin E, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.